The COVID-19 pandemic

References

• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265–269.
   PubMed Web of Science ®Google Scholar
• World Health Organization Coronavirus Disease 2019 (COVID-19) Situation Report-97. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200426-sitrep-97-covid-19.pdf
   Google Scholar
• Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473.
   PubMed Web of Science ®Google Scholar
• Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869–889.
   PubMed Web of Science ®Google Scholar
• Azhar EI, Hui DSC, Memish ZA, et al. The Middle East respiratory syndrome (MERS). Infect Dis Clin North Am. 2019;33(4):891–905.
   PubMed Web of Science ®Google Scholar
• Corman VM, Muth D, Niemeyer D, et al. Hosts and sources of endemic human coronaviruses. Adv Virus Res. 2018;100:163–188.
   PubMed Web of Science ®Google Scholar
• Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26:450–452.
   PubMed Web of Science ®Google Scholar
• Almazán F, Sola I, Zuñiga S, et al. Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res. 2014;189:262–270.
   PubMed Web of Science ®Google Scholar
• Nao N, Yamagishi J, Miyamoto H, et al. Genetic predisposition to acquire a polybasic cleavage site for highly pathogenic avian influenza virus hemagglutinin. mBio. 2017;8(1):e02298.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
   PubMed Web of Science ®Google Scholar
• Zhu N ,Zhang D ,Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58(7):1063–1069.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Fukushima EA, Levine M, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa674
   Google Scholar
• Wang CZ, Hu SL, Wang L, et al. Early risk factors of the exacerbation of coronavirus disease 2019 pneumonia. J Med Virol. 2020. DOI:10.1002/jmv.26071
   Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - a review. Life Sci. 2020;255:117839.
   PubMed Web of Science ®Google Scholar
• Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020. DOI:10.1016/j.ajem.2020.04.048
   Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
   PubMed Web of Science ®Google Scholar
• Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020;120(05):876–878.
   PubMed Web of Science ®Google Scholar
• Lang J, Yang N, Deng J, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. Plos One. 2011;6(8):e23710.
   PubMed Web of Science ®Google Scholar
• Vicenzi E, Canducci F, Pinna D, et al. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerging Infect Dis. 2004;10(3):413–418.
   PubMed Web of Science ®Google Scholar
• Belen-Apak FB, Sarialioglu F. The old but new: can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARSCoV2 by inhibition of host cell proteases? Med Hypotheses. 2020;142:109743.
   PubMed Web of Science ®Google Scholar
• Henry BM, Benoit SW, Santos de Oliveira MH, et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): a pooled analysis and review. Clin Biochem. 2020.;81:1–8. DOI:10.1016/j.clinbiochem.2020.05.012
   PubMed Web of Science ®Google Scholar
• Sanna G, Serrau G, Bassareo PP, et al. Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020. DOI:10.1007/s00431-020-03699-0
   PubMed Web of Science ®Google Scholar
• Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Med. 2020;26(5):676–680.
   PubMed Web of Science ®Google Scholar
• Han Q, Lin Q, Ni Z, et al. Uncertainties about the transmission routes of 2019 novel coronavirus. Influenza Other Respir Viruses. 2020;14(4):470–471.
   PubMed Web of Science ®Google Scholar
• Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–217.
   PubMed Web of Science ®Google Scholar
• Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936.
   PubMed Web of Science ®Google Scholar
• Núñez-Delgado A. What do we know about the SARS-CoV-2 coronavirus in the environment? Sci Total Environ. 2020;727:138647.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa149
   Web of Science ®Google Scholar
• Liu L, Wei Q, Alvarez X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011;85(8):4025–4030.
   PubMed Web of Science ®Google Scholar
• Chan VW, Chiu PK, Yee CH, et al. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J Urol. 2020. DOI:10.1007/s00345-020-03246-4
   PubMed Web of Science ®Google Scholar
• Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815.
   PubMed Web of Science ®Google Scholar
• Dong L, Tian J, He S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18):1846–1848.
   PubMed Web of Science ®Google Scholar
• Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Annals Intern Med. 2020. DOI:10.7326/M20-1176
   PubMed Web of Science ®Google Scholar
• Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39.
   PubMed Web of Science ®Google Scholar
• Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 2020;25(5):2000062.
   Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582.
   PubMed Web of Science ®Google Scholar
• The White House. Press Briefing by Members of the President’s Coronavirus Task Force. [cited 2020 Jan 31]. Available from: www.whitehouse.gov/briefings-statements/press-briefing-members-presidents-coronavirus-task-force
   Google Scholar
• European Centre for Disease Prevention and Control. Algorithm for the management of contacts of probable or confirmed COVID-19 cases. [cited 2020 Feb 25]. Available from: https://www.ecdc.europa.eu/en/publications-data/algorithm-management-contacts-probableor-confirmed-covid-19-cases.
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
   PubMedGoogle Scholar
• Reusken C, Broberg EK, Haagmans B, et al. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries. Euro Surveill. 2020;25(6):2000082.
   Google Scholar
• Chan JF, Yip CC, To KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58(5):pii: e0031020.
   Web of Science ®Google Scholar
• Cheng PK, Wong DA, Tong LK, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004;363(9422):1699–1700.
   PubMed Web of Science ®Google Scholar
• Al-Abdely HM, Midgley CM, Alkhamis AM, et al. Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia. Emerging Infect Dis. 2019;25(4):753–766.
   PubMed Web of Science ®Google Scholar
• Loeffelholz MJ, and, Tang Y-W. Laboratory diagnosis of emerging human coronavirus infections – the state of the art. Emerg Microb Infect. 2020;9:747–756.
   PubMed Web of Science ®Google Scholar
• Yelin I, Aharony N, Shaer Tamar E, et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa531
   Google Scholar
• Hogan CA, Sahoo MK, Pinsky BA. Sample pooling as a strategy to detect community tTransmission of SARS-CoV-2. JAMA. 2020;323(19):1967.
   PubMed Web of Science ®Google Scholar
• Wyllie AL, Fournier J, Casanovas-Massana A, et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv. 2020. DOI:10.1101/2020.04.16.20067835
   Google Scholar
• Wu Z-S, Zhang Z-Q, Wu S. Focus on the crosstalk between COVID-19 and urogenital systems. J Urol. 2020;204(1):7–8.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. New Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. CRISPR–Cas12-based detection of SARS-CoV-2. Nat Biotech. 2020. DOI:10.1038/s41587-020-0513-4
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan L-M, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656–657.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Lancet. 2020. DOI:10.1093/cid/ciaa344
   PubMedGoogle Scholar
• Zhang G, Nie S, Zhang Z, et al. Longitudinal change of SARS-Cov2 antibodies in patients with COVID-19. J Infect Dis. 2020. DOI:10.1093/infdis/jiaa229
   Google Scholar
• Long Q-X, Liu B-Z, Deng H-J, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Med. 2020;26:845–848.
   PubMed Web of Science ®Google Scholar
• Haveri A, Smura T, Kuivanen S, et al. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February. Euro Surveill. 2020;25(11):2000266.
   Google Scholar
• Amanat F, Stadlbauer D, Strohmeier S, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020. DOI:10.1101/2020.03.17.20037713
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Coughlin MM, Baker SC, et al. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One. 2012;7(11):e50366.
   PubMed Web of Science ®Google Scholar
• Group PIW, Multi-National P, Davey RT, Jr, et al. A randomized, controlled trial of zmapp for Ebola virus infection. N Engl J Med. 2016;375:1448–14456.
   PubMed Web of Science ®Google Scholar
• Wang C, Li W, Drabek D, et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11(1):2251.
   PubMed Web of Science ®Google Scholar
• Okba NMA, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020. DOI:10.3201/eid2607.200841
   Web of Science ®Google Scholar
• Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. JI. 2011;186(12):7264–7268.
   Google Scholar
• Foundation for Innovative New Diagnostics (FIND). 2020. Available from: https://www.finddx.org/covid-19/sarscov2-eval-immuno/
   Google Scholar
• Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236.
   PubMed Web of Science ®Google Scholar
• An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA. Technical Report, 1 April 2020. European Centre for Disease Prevention and Control. Stockholm, 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Overview-rapid-test-situation-for-COVID-19-diagnosis-EU-EEA.pdf
   Google Scholar
• Nuccetelli M, Grelli S, Ciotti M, et al. SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov. 2020;6:38.
   PubMed Web of Science ®Google Scholar
• Carter LJ, Garner LV, Smoot JW, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6(5):591–605.
   PubMed Web of Science ®Google Scholar
• Huang C, Wen T, Shi F-J, et al. Rapid detection of IgM antibodies against the SARS-CoV-2 virus via colloidal gold nanoparticle-based lateral-flow assay. ACS Omega. 2020;5(21):12550–12556.
   PubMed Web of Science ®Google Scholar
• Shen B, Zheng Y, Zhang X, et al. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG. Am J Transl Res. 2020;12(4):1348–1354.
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263.
   PubMed Web of Science ®Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562–569.
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. pii: S0092-8674(20)30262-2.
   PubMed Web of Science ®Google Scholar
• Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.
   PubMed Web of Science ®Google Scholar
• Wang W, Su B, Pang L, et al. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cell Mol Immunol. 2020;17(6):650–652.
   PubMed Web of Science ®Google Scholar
• Chu H, Zhou J, Wong BH, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213(6):904–914.
   PubMed Web of Science ®Google Scholar
• Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231–241.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47–59.
   PubMed Web of Science ®Google Scholar
• Hardwick JM, Youle RJ. SnapShot: BCL-2 proteins. Cell. 2009;138(2):404, 404.e1.
   PubMedGoogle Scholar
• Wei L, Sun S, Xu CH, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95–102.
   PubMed Web of Science ®Google Scholar
• Yeung M-L, Yao Y, Jia L, et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol. 2016;1(3):16004.
   PubMed Web of Science ®Google Scholar
• Tan Y-X, Tan THP, Lee M-R, et al. Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein. J Virol. 2007;81(12):6346–6355.
   PubMed Web of Science ®Google Scholar
• Tao X, Hill TE, Morimoto C, et al. Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J Virol. 2013;87(17):9953–9958.
   PubMed Web of Science ®Google Scholar
• Chen Y, Feng Z, Diao B, et al. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv. DOI:10.1101/2020.03.27.20045427
   Google Scholar
• Bordi L, Castilletti C, Falasca L, et al. Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics. Arch Virol. 2006;151(2):369–377.
   PubMed Web of Science ®Google Scholar
• Chan CM, Ma CW, Chan WY, et al. The SARS-coronavirus membrane protein induces apoptosis through modulating the Akt survival pathway. Arch Biochem Biophys. 2007;459(2):197–207.
   PubMed Web of Science ®Google Scholar
• Khan S, Fielding BC, Tan TH, et al. Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells. Virus Res. 2006;122(1–2):20–27.
   PubMed Web of Science ®Google Scholar
• Schaecher SR, Touchette E, Schriewer J, et al. Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol. 2007;81(20):11054–11068.
   PubMed Web of Science ®Google Scholar
• Tan YJ, Fielding BC, Goh PY, et al. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol. 2004;78(24):14043–14047.
   PubMed Web of Science ®Google Scholar
• Yuan X, Shan Y, Zhao Z, et al. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol J. 2005;2:66.
   PubMed Web of Science ®Google Scholar
• Chan C-M, Tsoi H, Chan W-M, et al. The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function. Int J Biochem Cell Biol. 2009;41(11):2232–2239.
   PubMed Web of Science ®Google Scholar
• Versteeg GA, Van De Nes PS, Bredenbeek PJ, et al. The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. J Virol. 2007;81(20):10981–10990.
   PubMed Web of Science ®Google Scholar
• Feng S, Shen C, Xia N, et al. Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med. 2020;8(5):434–436.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523.
   PubMed Web of Science ®Google Scholar
• Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389.
   PubMed Web of Science ®Google Scholar
• Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020;9(1):469–473.
   PubMed Web of Science ®Google Scholar
• Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New Engl J Med. 2020;382:1564–1567.
   PubMed Web of Science ®Google Scholar
• Suman R, Javaid M, Haleem A, et al. Sustainability of coronavirus on different surfaces. J Clin Exp Hepatol. 2020. DOI:10.1016/j.jceh.2020.04.020
   PubMed Web of Science ®Google Scholar
• Lippi G, Adeli K, Ferrari M, et al. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
   Google Scholar
• World Health Organization. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. Available from: https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts
   Google Scholar
• Ahn D-G, Shin H-J, Kim M-H, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313–324.
   PubMed Web of Science ®Google Scholar
• Handbook of COVID-19 Prevention and Treatment. Available from: https://www.alnap.org/help-library/handbook-of-covid-19-prevention-and-treatment
   Google Scholar
• World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. Available from: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-nCov)
   Google Scholar
• Knowles SR, Phillips EJ, Dresser L, et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis. 2003;37(8):1139–1142.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569–1578. [Published correction appears in Lancet. 2020;395(10238):1694.
   PubMed Web of Science ®Google Scholar
• Li HS, Kuok DIT, Cheung MC, et al. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East respiratory syndrome coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model. Antiviral Res. 2018;155:89–96.
   PubMed Web of Science ®Google Scholar
• Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th ed). [cited 2020 May 11]. Available from: http://kjfy.meetingchina.org/msite/news/show/cn/3337.html
   Google Scholar
• Xu CY, Lu SD, Ye X, et al. Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report. QJM. 2020. DOI:10.1093/qjmed/hcaa153
   Web of Science ®Google Scholar
• Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582–1589.
   PubMed Web of Science ®Google Scholar
• Prattes J, Valentin T, Hoenigl M, et al. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - a case report. Med Mycol Case Rep. 2020. DOI:10.1016/j.mmcr.2020.05.001
   PubMed Web of Science ®Google Scholar
• Pham DT, Toeg H, De Paulis R, et al. Establishment and management of mechanical circulatory support during the COVID-19 pandemic. Circulation. 2020. DOI:10.1161/CIRCULATIONAHA.120.047415
   Web of Science ®Google Scholar
• Gopalakrishnan A, Mossaid A, Lo KB, et al. Fulminant acute kidney injury in a young patient with novel coronavirus 2019. Cardiorenal Med. 2020. DOI:10.1159/000508179
   Web of Science ®Google Scholar
• Dastan F, Saffaei A, Mortazavi SM, et al. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19. J Glob Antimicrob Resist. 2020;21:340–341.
   PubMed Web of Science ®Google Scholar
• Yang XH, Sun RH, Zhao MY, et al. Expert recommendations on blood purification treatment protocol for patients with severe COVID-19: recommendation and consensus. Chronic Dis Transl Med. 2020;6(2):106-114.
   Google Scholar
• Zhao JP, Hu Y, Du TH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Chin J Tuber Respir Dis. 2020; 43:183–184.
   Google Scholar
• Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.
   PubMed Web of Science ®Google Scholar
• Correa H, Malloy-Diniz LF, Da Silva AG. Why psychiatric treatment must not be neglected during the COVID-19 pandemic. Braz J Psychiatry. 2020. DOI:10.1590/1516-4446-2020-0995
   Google Scholar
• Huang YF, Bai C, He F, et al. Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19). Pharmacol Res. 2020;158:104939.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423.
   PubMed Web of Science ®Google Scholar
• FasterCures. COVID-19 treatment and vaccine tracker. Available from: https://milkeninstitute.org/covid-19-tracker
   Google Scholar
• Colson P, Rolain J-M, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55(3):105923.
   PubMed Web of Science ®Google Scholar
• Study to ask: Does antimalarial drug prevent COVID-19? Available from: https://newsroom.uw.edu/news/does-antimalarial-drug-pre-vent-covid-19-study-seeks-answers
   Google Scholar
• Liu T, Luo S, Libby P, et al. Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients. Pharmacol Ther. 2020. DOI:10.1016/j.pharmthera.2020.107587
   Web of Science ®Google Scholar
• Cheng Y, Wong R, Soo YOY, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24(1):44–46.
   PubMed Web of Science ®Google Scholar
• Accorsi P, Berti P, de Angelis V, et al. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19. Blood Transfus. 2020;18(3):163–166.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Infection prevention and control during health care when novel coronavirus(nCoV) infection is suspected interim guidance. [cited 2020 Jan 25]. Available from: https://apps.who.int/iris/handle/10665/330674
   Google Scholar
• Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–306.
   PubMed Web of Science ®Google Scholar
• China’s development of vaccines against novel coronavirus. National Health Commission of the People’s Republic of China. Available from: http://en.nhc.gov.cn/2020-03/26/c_78336.htm
   Google Scholar
• Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020;12(3):254.
   PubMed Web of Science ®Google Scholar
• COVID-19 vaccine. Wikipedia. [2020 Apr 25; cited 2020 Apr 27]. Available from: https://en.wikipedia.org/w/index.php?title=COVID-19_vaccine&oldid=953116109
   Google Scholar
• Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine. 2020;55:102743.
   PubMed Web of Science ®Google Scholar
• Nunneley DCE. COVID-19 vaccine candidates: 6 front-runners. ABC News. 2020. Available from: https://abcnews.go.com/Health/covid-19-vaccine-candidates-front-runners/story?id=69881230
   Google Scholar
• Symvivo. COVID-19 program vision. Available from: https://www.symvivo.com/covid-19
   Google Scholar
• Singh S, Kumar R, Agrawal B. Adenoviral vector-based vaccines and gene therapies: current status and future prospects. London: IntechOpen; 2018.
   Google Scholar
• Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395(10240):1845–1854.
   PubMed Web of Science ®Google Scholar
• Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737–741.
   PubMed Web of Science ®Google Scholar
• Mo H, Zeng G, Ren X, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11(1):49–53.
   PubMed Web of Science ®Google Scholar
• Callow KA, Parry HF, Sergeant M, et al. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990;105(2):435–446.
   PubMed Web of Science ®Google Scholar
• Mashamba-Thompson TP, Crayton ED. Blockchain and artificial intelligence technology for novel coronavirus disease 2019 self-testing. Diagnostics. 2020;10(4):198.
   Web of Science ®Google Scholar
• McCall B. COVID-19 and artificial intelligence: protecting health-care workers and curbing the spread. Lancet Digit Health. 2020;2(4):e166–e167.
   PubMedGoogle Scholar
• Li L, Qin L, Xu Z, et al. Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT. Radiology. 2020. DOI:10.1148/radiol.2020200905
   Google Scholar
• Rao A, Vazquez JA. Identification of COVID-19 can be quicker through artificial intelligence framework using a mobile phone-based survey in the populations when cities/towns are under quarantine. Infect Control Hosp Epidemiol. 2020;3:1–18.
   Google Scholar
• Beck BR, Shin B, Choi Y, et al. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol J. 2020;18:784–790.
   PubMed Web of Science ®Google Scholar
• Senior AW, Evans R, Jumper J, et al. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706–710.
   PubMed Web of Science ®Google Scholar
• Rosenbaum L. Facing Covid-19 in Italy — ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med. 2020;382(20):1873–1875.
   PubMed Web of Science ®Google Scholar
• Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem. 1996;42(5):813–816.
   PubMed Web of Science ®Google Scholar
• Dietzen DJ. Unleashing the power of laboratory developed tests: CLOSING gaps in COVID diagnosis and beyond. J Applied Lab Med. 2020. DOI:10.1093/jalm/jfaa077
   Google Scholar